<?xml version="1.0"?>
<presentation title="Tae Jun Song" width="720.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{56011F40-7E06-4624-8180-B0CDA16E75F5}">
	<presenters>
		<presenter name="Tae Jun Song" title="Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea" email="" web="" phone="" photoAssetId="">
			<bio> EUS-guided RFA for tumor management</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets/>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
		<graphicAsset id="imgAsset18" src="thmb19.swf" embedded="0"/>
		<graphicAsset id="imgAsset19" src="thmb20.swf" embedded="0"/>
		<graphicAsset id="imgAsset20" src="thmb21.swf" embedded="0"/>
		<graphicAsset id="imgAsset21" src="thmb22.swf" embedded="0"/>
		<graphicAsset id="imgAsset22" src="thmb23.swf" embedded="0"/>
		<graphicAsset id="imgAsset23" src="thmb24.swf" embedded="0"/>
		<graphicAsset id="imgAsset24" src="thmb25.swf" embedded="0"/>
		<graphicAsset id="imgAsset25" src="thmb26.swf" embedded="0"/>
		<graphicAsset id="imgAsset26" src="thmb27.swf" embedded="0"/>
		<graphicAsset id="imgAsset27" src="thmb28.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<videoTracks>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24227376" width="240" height="180">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="15.2780000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24228530" width="240" height="180">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="25.9590000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24229435" width="240" height="180">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="15.5100000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24231120" width="240" height="180">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="36.1760000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24231947" width="240" height="180">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="16.8999996"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24232992" width="240" height="180">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="21.8799992"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24234006" width="240" height="180">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="20.8050000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24234942" width="240" height="180">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="20.2000000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24236050" width="240" height="180">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="20.6189995"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24236892" width="240" height="180">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="15.5570000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc2030.spr0_24237812" width="240" height="180">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="16.7600000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc2030.spr0_24238826" width="240" height="180">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="22.2399998"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc2030.spr0_24240745" width="240" height="180">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="48.1100000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc2030.spr0_24241868" width="240" height="180">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="25.8670000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24242804" width="240" height="180">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="16.8099995"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24244021" width="240" height="180">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="26.7490000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24245940" width="240" height="180">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="43.5600000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24246876" width="240" height="180">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="20.1499996"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24247797" width="240" height="180">
				<startTimestamp slideIndex="18" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="18" stepIndex="0" timeOffset="19.5499992"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24248733" width="240" height="180">
				<startTimestamp slideIndex="19" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="19" stepIndex="0" timeOffset="18.9470000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24249653" width="240" height="180">
				<startTimestamp slideIndex="20" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="20" stepIndex="0" timeOffset="18.8080000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24250979" width="240" height="180">
				<startTimestamp slideIndex="21" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="21" stepIndex="0" timeOffset="29.6280000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24251821" width="240" height="180">
				<startTimestamp slideIndex="22" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="22" stepIndex="0" timeOffset="12.0699997"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24252835" width="240" height="180">
				<startTimestamp slideIndex="23" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="23" stepIndex="0" timeOffset="20.0100000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24253865" width="240" height="180">
				<startTimestamp slideIndex="24" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="24" stepIndex="0" timeOffset="24.1480000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24255503" width="240" height="180">
				<startTimestamp slideIndex="25" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="25" stepIndex="0" timeOffset="39.0090000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24256033" width="240" height="180">
				<startTimestamp slideIndex="26" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="26" stepIndex="0" timeOffset="7.4760000"/>
			</videoTrack>
			<videoTrack volume="1.0000000" src="ispring.resources_23dc1e70.spr0_24257547" width="240" height="180">
				<startTimestamp slideIndex="27" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="27" stepIndex="0" timeOffset="35.4300000"/>
			</videoTrack>
		</videoTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="true"/>
					<button type="presenterInfo" visible="true"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>false</showPresenterInfo>
				<showPresenterVideo>true</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>true</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="never"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="EUS-guided RFA for tumor management" titleNormalized="eus-guided rfa for tumor management" src="slide1.swf" size="89444" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.2789997"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-guided RFA for tumor management
Tae Jun Song
Department of Internal Medicine, University of Ulsan College of Medicine, 
Asan Medical Center, Seoul, Korea</text>
		</slide>
		<slide index="1" title="Radiofrequency ablation (RFA)" titleNormalized="radiofrequency ablation (rfa)" src="slide2.swf" size="84477" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.9589991"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Radiofrequency ablation (RFA)
RFA works by emitting energy resulting in coagulative necrosis of the surrounding tissue.

RFA is considered a safe and potentially curative method for treatment of tumors of the liver, lung, and kidney.

It may be used as an alternative treatment method for pancreatic tumors.
Gastrointest Endosc 2012;76:1039-1043
Gastrointest Endosc Clin N Am. 2012;22:359-69</text>
		</slide>
		<slide index="2" title="Radiofrequency ablation (RFA)" titleNormalized="radiofrequency ablation (rfa)" src="slide3.swf" size="140290" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.5090002"/>
			</animationSteps>
			<notes>RFA uses electromagnetic energy to induce thermal injury to the target tissue.
The RFA system consists of RF electrode and RF generator. </notes>
			<notesNormalized>rfa uses electromagnetic energy to induce thermal injury to the target tissue.
the rfa system consists of rf electrode and rf generator.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;RFA uses electromagnetic energy to induce thermal injury to the target tissue.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The RFA system consists of RF electrode and RF generator. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Radiofrequency ablation (RFA)
RF electrode: metal shaft with conductive tip
RF generator:
Supplies RF power and produce RF voltage between active RF electrode and reference electrode
Establishes lines of electric field within patient’s body between two electrodes.
Gastrointest Endosc 2012;76:1039-1043
Gastrointest Endosc Clin N Am. 2012;22:359-69
(Starmed Co, Seoul, Korea)</text>
		</slide>
		<slide index="3" title="Radiofrequency ablation (RFA)" titleNormalized="radiofrequency ablation (rfa)" src="slide4.swf" size="121604" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="36.1790003"/>
			</animationSteps>
			<notes>Mechanism of tissue heating by RFA is that electric field oscillates with RF frequency and it cause oscillatory movement of ions in the tissue. Frictional energy associated with ionic current causes heat production. 
In monopolar RFA, a closed-loop circuit includes a RF generator, an electrode needle, a ground pad and the patient.</notes>
			<notesNormalized>mechanism of tissue heating by rfa is that electric field oscillates with rf frequency and it cause oscillatory movement of ions in the tissue. frictional energy associated with ionic current causes heat production. 
in monopolar rfa, a closed-loop circuit includes a rf generator, an electrode needle, a ground pad and the patient.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Mechanism of tissue heating by RFA is that electric field oscillates with RF frequency and it cause oscillatory movement of ions in the tissue. Frictional energy associated with ionic current causes heat production. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;In monopolar RFA, a closed-loop circuit includes a RF generator, an electrode needle, a ground pad and the patient.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Radiofrequency ablation (RFA)</text>
		</slide>
		<slide index="4" title="RFA of pancreas" titleNormalized="rfa of pancreas" src="slide5.swf" size="228129" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.8989996"/>
			</animationSteps>
			<notes>The first trial of EUS-RFA in porcine pancreas was reported in 1999.</notes>
			<notesNormalized>the first trial of eus-rfa in porcine pancreas was reported in 1999.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The first trial of EUS-RFA in porcine pancreas was reported in 1999.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RFA of pancreas
 Gastrointest Endosc 1999;50:392-401</text>
		</slide>
		<slide index="5" title="RFA of pancreas" titleNormalized="rfa of pancreas" src="slide6.swf" size="1890" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="21.8789992"/>
			</animationSteps>
			<notes>Clinicians’ reluctance to use RFA in the pancreas was related to well-founded fear of adverse effects, including thermal injury-induced pancreatitis and thermal damage to structures in and around the pancreas (eg, the duodenal wall, Vater papilla, nearby viscera and blood vessels), and to technical
limitations of the real-time imaging modalities used to visualize target lesions and of the radiofrequency (RF) electrodes used to ablate them.</notes>
			<notesNormalized>clinicians’ reluctance to use rfa in the pancreas was related to well-founded fear of adverse effects, including thermal injury-induced pancreatitis and thermal damage to structures in and around the pancreas (eg, the duodenal wall, vater papilla, nearby viscera and blood vessels), and to technical
limitations of the real-time imaging modalities used to visualize target lesions and of the radiofrequency (rf) electrodes used to ablate them.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Clinicians’ reluctance to use RFA in the pancreas was related to well-founded fear of adverse effects, including thermal injury-induced pancreatitis and thermal damage to structures in and around the pancreas (eg, the duodenal wall, Vater papilla, nearby viscera and blood vessels), and to technical&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;limitations of the real-time imaging modalities used to visualize target lesions and of the radiofrequency (RF) electrodes used to ablate them.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RFA of pancreas
Clinicians’ reluctance to use RFA in the pancreas was related to well-founded fear of adverse events 
Thermal injury-induced pancreatitis 
Thermal damage to structures in and around the pancreas (e.g., the duodenal wall, ampulla of Vater, nearby viscera and blood vessels) 
Technical limitations
 Pancreas 2014;43:938–945</text>
		</slide>
		<slide index="6" title="RFA of pancreas" titleNormalized="rfa of pancreas" src="slide7.swf" size="104101" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.8089995"/>
			</animationSteps>
			<notes>In the past, severe adverse events including necrotizing pancreatitis or serious bleeding were reported. These adverse events made physician hesitate to perform EUS-RFA.</notes>
			<notesNormalized>in the past, severe adverse events including necrotizing pancreatitis or serious bleeding were reported. these adverse events made physician hesitate to perform eus-rfa.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In the past, severe adverse events including necrotizing pancreatitis or serious bleeding were reported. These adverse events made physician hesitate to perform EUS-RFA.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RFA of pancreas
 EJSO 2004;30:85-7
 J Surg Oncol 2006;94:392-5</text>
		</slide>
		<slide index="7" title="Experimental studies in animals" titleNormalized="experimental studies in animals" src="slide8.swf" size="147020" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.1990008"/>
			</animationSteps>
			<notes>Recently, with the development of devices and interventional EUS technique, experimental studies in animals have shown that RFA of pancreatic tissue is technically feasible and safe.</notes>
			<notesNormalized>recently, with the development of devices and interventional eus technique, experimental studies in animals have shown that rfa of pancreatic tissue is technically feasible and safe.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Recently, with the development of devices and interventional EUS technique, experimental studies in animals have shown that RFA of pancreatic tissue is technically feasible and safe.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Experimental studies in animals 
Endoscopy 2014;46:411-5
Gastrointest Endosc 2009;70:372-6
Gastroenterol Research &amp; Practice2012; 1-6</text>
		</slide>
		<slide index="8" title="" titleNormalized="" src="slide9.swf" size="357783" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.6179995"/>
			</animationSteps>
			<notes>In our center, EUS-guided RFA was also tried using pig model. </notes>
			<notesNormalized>in our center, eus-guided rfa was also tried using pig model.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In our center, EUS-guided RFA was also tried using pig model. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Gastrointest Endosc 2012;76:1039-1043</text>
		</slide>
		<slide index="9" title="Potential indications of EUS-RFA" titleNormalized="potential indications of eus-rfa" src="slide10.swf" size="1553" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="15.5590004"/>
			</animationSteps>
			<notes>Potential indications of EUS-RFA may be </notes>
			<notesNormalized>potential indications of eus-rfa may be</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Potential indications of EUS-RFA may be &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Potential indications of EUS-RFA
Unresectable pancreatic cancer
Pancreatic cystic tumor
Neuroendocrine tumor
Hepatic tumor</text>
		</slide>
		<slide index="10" title="EUS-RFA of pancreatic tumors" titleNormalized="eus-rfa of pancreatic tumors" src="slide11.swf" size="86366" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.7590002"/>
			</animationSteps>
			<notes>Previous human trial of EUS-RFA was performed for pancreatic cystic tumor or neuroendocrine tumor. </notes>
			<notesNormalized>previous human trial of eus-rfa was performed for pancreatic cystic tumor or neuroendocrine tumor.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Previous human trial of EUS-RFA was performed for pancreatic cystic tumor or neuroendocrine tumor. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-RFA of pancreatic tumors
 World J Gastrointest Surg 2015;7:52-9</text>
		</slide>
		<slide index="11" title="EUS-RFA of pancreatic cancer: Human trial" titleNormalized="eus-rfa of pancreatic cancer: human trial" src="slide12.swf" size="1617" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="22.2389998"/>
			</animationSteps>
			<notes>In our center, IRB approved the following cases as inclusion criteria for EUS-RFA.</notes>
			<notesNormalized>in our center, irb approved the following cases as inclusion criteria for eus-rfa.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In our center, IRB approved the following cases as inclusion criteria for EUS-RFA.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-RFA of pancreatic cancer: Human trial
IRB approved inclusion criteria
Histologically confirmed pancreatic cancer
Advanced &amp; unresectable cases
Failure to chemotherapy
</text>
		</slide>
		<slide index="12" title="EUS-RFA of pancreatic cancer: Human trial" titleNormalized="eus-rfa of pancreatic cancer: human trial" src="slide13.swf" size="207633" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="48.1090006"/>
			</animationSteps>
			<notes>EUS-guided RFA was performed by using 18G RFA needle and  a VIVA RF generator. 
Total length of the electrode including the delivery system was 150 cm. 
The exposed distal end of the electrode was needle-shaped and echogenic. 
The length of exposed tip of RFA electrode was 10mm. 
During ablation, the RF electrode was cooled and perfused internally with circulating chilled saline solution delivered via a pump.</notes>
			<notesNormalized>eus-guided rfa was performed by using 18g rfa needle and a viva rf generator. 
total length of the electrode including the delivery system was 150 cm. 
the exposed distal end of the electrode was needle-shaped and echogenic. 
the length of exposed tip of rfa electrode was 10mm. 
during ablation, the rf electrode was cooled and perfused internally with circulating chilled saline solution delivered via a pump.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;EUS-guided RFA was performed by using 18G RFA needle and  a VIVA RF generator. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Total length of the electrode including the delivery system was 150 cm. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The exposed distal end of the electrode was needle-shaped and echogenic. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The length of exposed tip of RFA electrode was 10mm. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;During ablation, the RF electrode was cooled and perfused internally with circulating chilled saline solution delivered via a pump.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-RFA of pancreatic cancer: Human trial
18-gauge endoscopic RFA electrode 
VIVA RF generator (STARmed, Korea) 
The length of exposed tip of RFA electrode was 10mm</text>
		</slide>
		<slide index="13" title="RFA for large tumor" titleNormalized="rfa for large tumor" src="slide14.swf" size="223070" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="25.8690008"/>
			</animationSteps>
			<notes>RF ablation only takes advantage of temperature that are sufficient to induce coagulation necrosis. 
RFA electrode creates  a central zone of  high temperatures in the tissue immediately around the electrode and surrounded by more peripheral zones of sub-optimal tissue heating. </notes>
			<notesNormalized>rf ablation only takes advantage of temperature that are sufficient to induce coagulation necrosis. 
rfa electrode creates a central zone of high temperatures in the tissue immediately around the electrode and surrounded by more peripheral zones of sub-optimal tissue heating.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;RF ablation only takes advantage of temperature that are sufficient to induce coagulation necrosis. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;RFA electrode creates  a central zone of  high temperatures in the tissue immediately around the electrode and surrounded by more peripheral zones of sub-optimal tissue heating. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RFA for large tumor
Chemistry &amp; Physics of Lipids 2012;165:424-37</text>
		</slide>
		<slide index="14" title="Summation of ablation zone for large tumor ablation" titleNormalized="summation of ablation zone for large tumor ablation" src="slide15.swf" size="193181" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="16.8089995"/>
			</animationSteps>
			<notes>For the large tumor, multiple ablations in different sites are necessary to avoid major vessel injury due to heat injury and to secure effective ablation. </notes>
			<notesNormalized>for the large tumor, multiple ablations in different sites are necessary to avoid major vessel injury due to heat injury and to secure effective ablation.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;For the large tumor, multiple ablations in different sites are necessary to avoid major vessel injury due to heat injury and to secure effective ablation. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Summation of ablation zone
for large tumor ablation
Multiple ablation</text>
		</slide>
		<slide index="15" title="RFA of pancreatic cancer" titleNormalized="rfa of pancreatic cancer" src="slide16.swf" size="449426" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="26.7490000"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>RFA of pancreatic cancer</text>
		</slide>
		<slide index="16" title="RFA of pancreatic cancer" titleNormalized="rfa of pancreatic cancer" src="slide17.swf" size="148892" advanceOnTime="1" framesCount="977" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video0" videoClipId="ispring.resources_235de200.spr0_24204943" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_235de200.spr2_24204943" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video0" startPos="0.0000000"/>
				<pauseVideo frameIndex="976" videoId="video0"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="976" playTime="40.6666667" pauseTime="2.8933347"/>
			</animationSteps>
			<notes>After insertion of the RFA electrode into the mass, the RF generator was activated to deliver 50 W ablation power. The ablation was performed for 10 seconds at one site. The ablation was repeated at different sites. Initially, ablation began at the right distal portion of the mass on EUS image while withdrawing the RFA electrode, and then the RFA electrode was re-inserted and ablation was repeated at the left side of the previous site.</notes>
			<notesNormalized>after insertion of the rfa electrode into the mass, the rf generator was activated to deliver 50 w ablation power. the ablation was performed for 10 seconds at one site. the ablation was repeated at different sites. initially, ablation began at the right distal portion of the mass on eus image while withdrawing the rfa electrode, and then the rfa electrode was re-inserted and ablation was repeated at the left side of the previous site.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;After insertion of the RFA electrode into the mass, the RF generator was activated to deliver 50 W ablation power. The ablation was performed for 10 seconds at one site. The ablation was repeated at different sites. Initially, ablation began at the right distal portion of the mass on EUS image while withdrawing the RFA electrode, and then the RFA electrode was re-inserted and ablation was repeated at the left side of the previous site.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>RFA of pancreatic cancer
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="17" title="66 y/o male, pancreas head cancer" titleNormalized="66 y/o male, pancreas head cancer" src="slide18.swf" size="157876" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.1489996"/>
			</animationSteps>
			<notes>Let me show you the case.
66 year old mas had pancreas head cancer. Despite of SBRT, gemcitabine-based chemotherapy and 2nd line Folfox chemotherapy, the tumor progressed. We decided to perform EUS-RFA</notes>
			<notesNormalized>let me show you the case.
66 year old mas had pancreas head cancer. despite of sbrt, gemcitabine-based chemotherapy and 2nd line folfox chemotherapy, the tumor progressed. we decided to perform eus-rfa</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Let me show you the case.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;66 year old mas had pancreas head cancer. Despite of SBRT, gemcitabine-based chemotherapy and 2nd line Folfox chemotherapy, the tumor progressed. We decided to perform EUS-RFA&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>66 y/o male, pancreas head cancer
Metal stent guided SBRT (26Gy/4 Fr)
Gemcitabine + erlotinib chemotherapy #4
Folfox #3
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="18" title="66 y/o male, pancreas head cancer" titleNormalized="66 y/o male, pancreas head cancer" src="slide19.swf" size="256388" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset18" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.5489992"/>
			</animationSteps>
			<notes>Because of the duodenal obstruction, balloon dilatation was performed to insert the linear EUS scope. But the linear EUS scope could not pass. So the forward-viewing EUS scope was used.</notes>
			<notesNormalized>because of the duodenal obstruction, balloon dilatation was performed to insert the linear eus scope. but the linear eus scope could not pass. so the forward-viewing eus scope was used.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Because of the duodenal obstruction, balloon dilatation was performed to insert the linear EUS scope. But the linear EUS scope could not pass. So the forward-viewing EUS scope was used.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>66 y/o male, pancreas head cancer
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="19" title="66 y/o male, pancreas head cancer" titleNormalized="66 y/o male, pancreas head cancer" src="slide20.swf" size="301691" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset19" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.9490008"/>
			</animationSteps>
			<notes>The ablation power was 50 W and the duration was 10 seconds. 
The ablation was repeated 8 times at the different site.</notes>
			<notesNormalized>the ablation power was 50 w and the duration was 10 seconds. 
the ablation was repeated 8 times at the different site.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The ablation power was 50 W and the duration was 10 seconds. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;The ablation was repeated 8 times at the different site.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>66 y/o male, pancreas head cancer
50W, 10 sec
continuous mode
x 8 times
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="20" title="66 y/o male, pancreas head cancer" titleNormalized="66 y/o male, pancreas head cancer" src="slide21.swf" size="211893" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset20" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="18.8089995"/>
			</animationSteps>
			<notes>The CT scan on one month after RFA showed necrosis of the tumor and some air bubbles inside the mass. But there was no evidence of duodenal fistula or abscess.</notes>
			<notesNormalized>the ct scan on one month after rfa showed necrosis of the tumor and some air bubbles inside the mass. but there was no evidence of duodenal fistula or abscess.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;The CT scan on one month after RFA showed necrosis of the tumor and some air bubbles inside the mass. But there was no evidence of duodenal fistula or abscess.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>66 y/o male, pancreas head cancer
One month after EUS-RFA
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="21" title="How to increase the effect of RFA" titleNormalized="how to increase the effect of rfa" src="slide22.swf" size="1880" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset21" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="29.6289992"/>
			</animationSteps>
			<notes>RFA for advanced pancreatic cancer is a type of cytoreductive therapy that does not aim to eradicate the tumor. 
Combined multi-treatment followed by RFA can prolong survival. 
For the treatment of advanced pancreatic cancer, systemic control with chemotherapy is needed in addition to local control of the disease. </notes>
			<notesNormalized>rfa for advanced pancreatic cancer is a type of cytoreductive therapy that does not aim to eradicate the tumor. 
combined multi-treatment followed by rfa can prolong survival. 
for the treatment of advanced pancreatic cancer, systemic control with chemotherapy is needed in addition to local control of the disease.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;RFA for advanced pancreatic cancer is a type of cytoreductive therapy that does not aim to eradicate the tumor. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;Combined multi-treatment followed by RFA can prolong survival. &lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font size="12"&gt;For the treatment of advanced pancreatic cancer, systemic control with chemotherapy is needed in addition to local control of the disease. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>How to increase the effect of RFA 
RFA for advanced pancreatic cancer is a type of cytoreductive therapy that does not aim to eradicate the tumor. 
Combined multi-treatment followed by RFA can prolong survival. 
For the treatment of advanced pancreatic cancer, systemic control with chemotherapy is needed in addition to local control of the disease. 
 Pancreas 2014;43:938–945</text>
		</slide>
		<slide index="22" title="How to increase the effect Chemistry" titleNormalized="how to increase the effect chemistry" src="slide23.swf" size="100253" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset22" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="12.0689997"/>
			</animationSteps>
			<notes>With RFA, additional chemotherapeutic agent was reported to be effective in the control of tumor.</notes>
			<notesNormalized>with rfa, additional chemotherapeutic agent was reported to be effective in the control of tumor.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;With RFA, additional chemotherapeutic agent was reported to be effective in the control of tumor.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>How to increase the effect 
Chemistry &amp; Physics of Lipids 2012;165:424-37</text>
		</slide>
		<slide index="23" title="CE-EUS after RFA" titleNormalized="ce-eus after rfa" src="slide24.swf" size="269406" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset23" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="20.0090002"/>
			</animationSteps>
			<notes>Post-RFA CE-EUS revealed increased blood flow around the RFA site and it may enhance the effect of systemic chemotherapy. </notes>
			<notesNormalized>post-rfa ce-eus revealed increased blood flow around the rfa site and it may enhance the effect of systemic chemotherapy.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Post-RFA CE-EUS revealed increased blood flow around the RFA site and it may enhance the effect of systemic chemotherapy. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>CE-EUS after RFA
CE-EUS: early enhancement of RFA site
 → increased blood flow 
</text>
		</slide>
		<slide index="24" title="43 y/o male, MEN 1" titleNormalized="43 y/o male, men 1" src="slide25.swf" size="237626" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset24" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="24.1489996"/>
			</animationSteps>
			<notes>43 year old man had multiple endocrine neoplasia type 1. Neuroendocrine tumor at the pancreas body was newly detected. </notes>
			<notesNormalized>43 year old man had multiple endocrine neoplasia type 1. neuroendocrine tumor at the pancreas body was newly detected.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;43 year old man had multiple endocrine neoplasia type 1. Neuroendocrine tumor at the pancreas body was newly detected. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>43 y/o male, MEN 1
16YA distal pancreatectomy d/t tail tumor 
 adrenalectomy d/t Cushing syndrome
4YA &amp; 2YA ependymoma &amp; syringomyelia → op.
1YA parathyroid adenoma → parathyroidectomy
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="25" title="EUS-RFA of pancreatic NET" titleNormalized="eus-rfa of pancreatic net" src="slide26.swf" size="113070" advanceOnTime="1" framesCount="809" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset25" presenterIndex="0">
			<sounds/>
			<videos>
				<video id="video1" videoClipId="ispring.resources_26a7c7d0.spr0_24214319" slides="1" repeat="1" volume="0.8000000" posterFrameId="ispring.resources_26a7c7d0.spr2_24214319" playFullScreen="0" hideWhenNotPlaying="0" rewindAfterPlaying="0"/>
			</videos>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands>
				<playVideo frameIndex="0" videoId="video1" startPos="0.0000000"/>
				<pauseVideo frameIndex="808" videoId="video1"/>
			</videoCommands>
			<animationSteps>
				<step start="0" end="808" playTime="33.6666667" pauseTime="5.3433317"/>
			</animationSteps>
			<notes>RFA was performed as the same technique.</notes>
			<notesNormalized>rfa was performed as the same technique.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;RFA was performed as the same technique.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>EUS-RFA of pancreatic NET
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="26" title="F/U after EUS-RFA" titleNormalized="f/u after eus-rfa" src="slide27.swf" size="155063" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset26" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="7.4790000"/>
			</animationSteps>
			<notes>Follow-up CT scan showed necrosis of the tumor.</notes>
			<notesNormalized>follow-up ct scan showed necrosis of the tumor.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Follow-up CT scan showed necrosis of the tumor.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>F/U after EUS-RFA
1 month after EUS-RFA
MRI before EUS-RFA
Courtesy of Prof. Dong Wan Seo</text>
		</slide>
		<slide index="27" title="EUS-RFA of pancreatic tumor" titleNormalized="eus-rfa of pancreatic tumor" src="slide28.swf" size="250185" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset27" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="35.4290003"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>EUS-RFA of pancreatic tumor
Still investigational in many areas
Needs more data &amp; refinement of devices 
Combination with other treatment modalities
Great potential for future treatment of various tumors</text>
		</slide>
	</slides>
</presentation>
